McFarland Clinic Taps Nabla to Support Clinicians and Streamline Documentation in Epic
Following a successful pilot, Nabla is now used across 12 specialties at McFarland Clinic to help clinicians spend less time on...
Following a successful pilot, Nabla is now used across 12 specialties at McFarland Clinic to help clinicians spend less time on...
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria...
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through...
SAN FRANCISCO, May 14, 2025 /PRNewswire/ -- The global artificial intelligence in diagnostics market size is expected to reach USD 5.44...
Accomplishment highlights the company's commitment to quality, excellence in credentialing, and ongoing advancements in patient care FORT MYERS, Fla., May...
Renowned Neurologist and Epilepsy Advocate Honored for Decades of Innovation in Therapeutics, Research, and Patient Care BOWIE, Md., May 14,...
With a Growing List of 30+ Global Customers, Including Top Pharma, PhaseV is Poised to Transform Clinical Development at Scale...
— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular...
- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is...
HOUSTON, TX, May 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader...
TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the...
QUEBEC CITY, May 7, 2025 /PRNewswire/ - Zilia Inc. (''Zilia''), a medical technology company pioneering the use of the eye...
VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Pramana Pharmaceuticals, a late-stage preclinical biopharmaceutical company developing a transformative small...
ATH434 Phase 2 Data to be Presented at Opening Plenary SessionMELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE)...
Clene preparing for upcoming meeting in the second quarter with the U.S. Food and Drug Administration (FDA) to reach agreement...
Clario strengthens its leadership in digital endpoint data collection with the acquisition of WCG's eCOA business, enhancing support for neuroscience...
VALBY, Denmark, May 6, 2025 /PRNewswire/ -- H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for AI...
Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing...
Arbor Scientia Group continues paving the way in medical education, combining excellence in scientific storytelling and optimization of submission processes...
SAN DIEGO, April 29, 2025 /PRNewswire/ -- Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at...